Treatment patterns and outcomes among patients with small-cell lung cancer (SCLC) in Europe: a retrospective cohort study

Objective Describe characteristics, treatment patterns and clinical outcomes of patients with small-cell lung cancer (SCLC).Design Retrospective chart review study defining several cohorts: (1) limited-stage disease (LD) SCLC initiating 1L therapy (1 L LD-SCLC), (2) extensive-stage disease (ED) SCLC...

Full description

Bibliographic Details
Published in:	BMJ Open
Main Authors:	Nuria Lara, Montserrat Roset, Fiona Blackhall, Nicolas Girard, Laura McDonald, Alain Livartowski, Ariadna Juarez García
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-02-01
Online Access:	https://bmjopen.bmj.com/content/13/2/e052556.full

Similar Items

Small cell lung cancer (SCLC): At the door of targeted therapies
by: Krešimir Tomić, et al.
Published: (2025-08-01)

Characterization of a new small cell lung cancer (SCLC) cell line STP54 derived from a metastatic bioptate of a combined type of SCLC with Non-SCLC component.
by: Joanna Domagała-Kulawik, et al.
Published: (2009-05-01)

State of the art in treatment of small cell lung cancer
by: Roya Behrouzi, et al.
Published: (2025-09-01)

Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC
by: Masaaki Yamamoto, et al.
Published: (2024-09-01)

Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth
by: Spenser S. Johnson, et al.
Published: (2024-12-01)

Chemotherapy for small cell lung cancer (SCLC): standards of care for first presentation and relapse
by: Graham Ross
Published: (2004-03-01)

Tracheal polypoid combined small cell lung cancer (C‐SCLC): A case report
by: Alberto Testori, et al.
Published: (2021-07-01)

Associations between four insulin resistance (IR) surrogates and the risk of small cell lung cancer (SCLC)
by: Yuedong Wang, et al.
Published: (2025-07-01)

Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)
by: Stéphanie L. Mercier, et al.
Published: (2022-12-01)

Non-neuroendocrine differentiation generates a ferroptosis-prone lipidome in small cell lung cancer (SCLC)
by: Christina M. Bebber, et al.
Published: (2021-07-01)

AN UNORTHODOX PRESENTATION OF SCLC
by: Ruchee Khanna
Published: (2018-10-01)

Liquid Biopsy in Small Cell Lung Cancer—A Route to Improved Clinical Care?
by: Matt Church, et al.
Published: (2020-12-01)

New developments in immunotherapy for SCLC
by: Zhonglin Hao, et al.
Published: (2025-01-01)

A Case of Metastatic Uterine Tumor Originating from Small-Cell Lung Cancer (SCLC) Mimicking Uterine Sarcoma
by: Mariko Fujima, et al.
Published: (2021-01-01)

Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: a retrospective observational study
by: Roni Weisshof, et al.
Published: (2023-11-01)

Hope on the Horizon: Emerging Therapies for SCLC
by: Sebastian Kraus
Published: (2025-09-01)

What's New in SCLC? A Review
by: Bryan Oronsky, et al.
Published: (2017-10-01)

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients: a comprehensive approach
by: Dimitrios Papakonstantinou, et al.
Published: (2025-07-01)

573 BTN1A1-Targeted Immunotherapy Combined with Standard Therapy in Small Cell Lung Cancer (SCLC) and Colorectal Cancer
by: Soohyeon Lee, et al.
Published: (2023-11-01)

Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis
by: Arani Sathiyapalan, et al.
Published: (2022-11-01)

An in silico comparative transcriptome analysis identifying hub lncRNAs and mRNAs in brain metastatic small cell lung cancer (SCLC)
by: Arsham Mikaeili Namini, et al.
Published: (2022-10-01)

Assessment of targets of antibody drug conjugates in SCLC
by: Abhishek Ajay, et al.
Published: (2025-01-01)

Efficacy of carboplatin–etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis
by: Igor Gomez-Randulfe, et al.
Published: (2024-09-01)

The Efficacy and Safety of Brain Radiotherapy Combined With Immune Checkpoint Inhibitors (ICIs) for Small‐Cell Lung Cancer (SCLC) Patients With Brain Metastases (BMs)
by: Jie Xu, et al.
Published: (2025-06-01)

Consolidative and salvage thoracic radiotherapy (TRT) in extensive-stage small-cell lung cancer (ES-SCLC) with first-line chemoimmunotherapy: a retrospective study from a single cancer center
by: Aihua Lan, et al.
Published: (2025-02-01)

First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
by: Laura Moliner, MD, et al.
Published: (2025-01-01)

Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC)
by: Ting Zhou, et al.
Published: (2017-04-01)

Organoids as a Systems Platform for SCLC Brain Metastasis
by: Vito Quaranta, et al.
Published: (2022-04-01)

Development and Validation of a Simplified Prognostic Score in SCLC
by: Elodie Negre, MD, et al.
Published: (2020-03-01)

Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study
by: Jiaping Liu, et al.
Published: (2024-06-01)

Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
by: Kathrin Kahnert, et al.
Published: (2023-11-01)

Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation
by: Jie Huang, et al.
Published: (2024-05-01)

Social Work Education and Training in Europe and the Bologna Process
by: Christine LabontÃ©-Roset
Published: (2004-01-01)

Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLC
by: Sami Ul Haq, MSc, et al.
Published: (2024-12-01)

Immunotherapy in refractory SCLC: the caterpillar struggling to become a butterfly
by: Antonio Passaro, et al.
Published: (2018-11-01)

Autophagic flux modulates tumor heterogeneity and lineage plasticity in SCLC
by: Yujie Hao, et al.
Published: (2025-01-01)

ADCs and TCE in SCLC Therapy: The Beginning of a New Era?
by: Paola Muscolino, et al.
Published: (2025-04-01)

Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment
by: Ying-Chun Lo, MD, PhD, et al.
Published: (2023-09-01)

Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC
by: Umit Tapan, MD, et al.
Published: (2021-01-01)

Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
by: Jin Yujuan, et al.
Published: (2023-05-01)